Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts

Cell Biology International

Volumn 33, Issue 11, 2009, Pages 1184-1193

  Gai, Hui ^a   Leung, Elaine Lai Han ^a   Costantino, Peter D ^b   Aguila, Jerell R ^a   Nguyen, David M ^a   Fink, Louis M ^a   Ward, David C ^a   Ma, Yupo ^a  

^a NEVADA CANCER INSTITUTE   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

Cardiomyocytes; Differentiation; Embryonic stem cells; Induced pluripotent stem cells; Somatic cell reprogramming

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AZACITIDINE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM CHANNEL BLOCKING AGENT; DIMETHYL SULFOXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FIBROBLAST; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; DIMETHYL SULFOXIDE; EMBRYONIC STEM CELLS; FIBROBLASTS; FORESKIN; FREE RADICAL SCAVENGERS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; ION CHANNELS; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RECEPTORS, ADRENERGIC; TRANSCRIPTION, GENETIC;

IPS;

EID: 70350605496     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.08.008     Document Type: Article

References (31)

1. Antonitsis P., Ioannidou-Papagiannaki E., Kaidoglou A., Charokopos N., Kalogeridis A., Kouzi-Koliakou K., et al. Cardiomyogenic potential of human adult bone marrow mesenchymal stem cells in vitro. Thorac Cardiovasc Surg 56 (2008) 77-82
2. Balana B., Nicoletti C., Zahanich I., Graf E.M., Christ T., Boxberger S., et al. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res 16 (2006) 949-960
3. Bin Z., Sheng L.G., Gang Z.C., Hong J., Jun C., Bo Y., et al. Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol Int 30 (2006) 769-776
4. Boheler K.R., Czyz J., Tweedie D., Yang H.T., Anisimov S.V., and Wobus A.M. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ Res 91 (2002) 189-201
5. Choi S.C., Yoon J., Shim W.J., Ro Y.M., and Lim D.S. 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells. Exp Mol Med 36 (2004) 515-523
6. Cowan C.A., Klimanskaya I., McMahon J., Atienza J., Witmyer J., Zucker J.P., et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 350 (2004) 1353-1356
7. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321 (2008) 1218-1221
8. Edwards M.K., Harris J.F., and McBurney M.W. Induced muscle differentiation in an embryonal carcinoma cell line. Mol Cell Biol 3 (1983) 2280-2286
9. Fang Z.F., Jin F., Gai H., Chen Y., Wu L., Liu A.L., et al. Human embryonic stem cell lines derived from the Chinese population. Cell Res 15 (2005) 394-400
10. Frey N., McKinsey T.A., and Olson E.N. Decoding calcium signals involved in cardiac growth and function. Nat Med 6 (2000) 1221-1227
11. Goh G., Self T., Barbadillo Munoz M.D., Hall I.P., Young L., and Denning C. Molecular and phenotypic analyses of human embryonic stem cell-derived cardiomyocytes: opportunities and challenges for clinical translation. Thromb Haemost 94 (2005) 728-737
12. He J.Q., Ma Y., Lee Y., Thomson J.A., and Kamp T.J. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 93 (2003) 32-39
13. Huangfu D., Osafune K., Maehr R., Guo W., Eijkelenboom A., Chen S., et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26 (2008) 1269-1275
14. Kamp T.J., and He J.Q. L-type Ca2+ channels gaining respect in heart failure. Circ Res 91 (2002) 451-453
15. Kehat I., Kenyagin-Karsenti D., Snir M., Segev H., Amit M., Gepstein A., et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108 (2001) 407-414
16. Kim Y.Y., Ku S.Y., Jang J., Oh S.K., Kim H.S., Kim S.H., et al. Use of long-term cultured embryoid bodies may enhance cardiomyocyte differentiation by BMP2. Yonsei Med J 49 (2008) 819-827
17. Mauritz C., Schwanke K., Reppel M., Neef S., Katsirntaki K., Maier L.S., et al. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 118 (2008) 507-517
18. Mummery C., Ward-van Oostwaard D., Doevendans P., Spijker R., van den Brink S., Hassink R., et al. Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation 107 (2003) 2733-2740
19. Narazaki G., Uosaki H., Teranishi M., Okita K., Kim B., Matsuoka S., et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 118 (2008) 498-506
20. Pal R., and Khanna A. Similar pattern in cardiac differentiation of human embryonic stem cell lines, BG01V and ReliCellhES1, under low serum concentration supplemented with bone morphogenetic protein-2. Differentiation 75 (2007) 112-122
21. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., et al. Disease-specific induced pluripotent stem cells. Cell 134 (2008) 877-886
22. Schenke-Layland K., Rhodes K.E., Angelis E., Butylkova Y., Heydarkhan-Hagvall S., Gekas C., et al. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Stem Cells 26 (2008) 1537-1546
23. Segev H., Kenyagin-Karsenti D., Fishman B., Gerecht-Nir S., Ziskind A., Amit M., et al. Molecular analysis of cardiomyocytes derived from human embryonic stem cells. Dev Growth Differ 47 (2005) 295-306
24. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131 (2007) 861-872
25. Tateishi K., He J., Taranova O., Liang G., D'Alessio A.C., and Zhang Y. Generation of insulin-secreting islet-like clusters from human skin fibroblasts. J Biol Chem 283 (2008) 31601-31607
26. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
27. Wei H., Juhasz O., Li J., Tarasova Y.S., and Boheler K.R. Embryonic stem cells and cardiomyocyte differentiation: phenotypic and molecular analyses. J Cell Mol Med 9 (2005) 804-817
28. Xu C., Police S., Rao N., and Carpenter M.K. Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91 (2002) 501-508
29. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318 (2007) 1917-1920
30. Zhang F., and Pasumarthi K.B. Embryonic stem cell transplantation: promise and progress in the treatment of heart disease. BioDrugs 22 (2008) 361-374
31. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104 (2009) e30-e41